These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 4384691)
1. [Treatment of some vascular diseases with the use of oxyphenyl-oxybutylamino-ethanol]. Berezovsky M; Berstein S Prensa Med Argent; 1966 Sep; 53(36):1964-71. PubMed ID: 4384691 [No Abstract] [Full Text] [Related]
2. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases]. Giulini SM; Agus GB; De Cristoforo A Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376 [No Abstract] [Full Text] [Related]
3. [Arterial insufficiency in the lower extremities treated with drugs]. Genster HG; Oram V Ugeskr Laeger; 1971 Feb; 133(6):244-6. PubMed ID: 4926100 [No Abstract] [Full Text] [Related]
4. [Testosterone and the prostate gland]. Winther O Nord Med; 1970 May; 83(20):624-6. PubMed ID: 5426430 [No Abstract] [Full Text] [Related]
5. [On drug therapy of phlebopathies of the lower extremities with trihydroxyethylrutoside and trihydroxyethylrutoside associated with adrenochromomonosemicarbazone]. Bagliani A; Taborelli R; Parravicini R Minerva Cardioangiol; 1973 Dec; 21(12):775-88. PubMed ID: 4780269 [No Abstract] [Full Text] [Related]
6. [Local action of hyaluronic acid on reparative processes of the connective tissue. Clinical results]. Reggianini V Osp Ital Chir; 1968 Aug; 19(2):173-88. PubMed ID: 5743183 [No Abstract] [Full Text] [Related]
7. [Clinical experimentation on the tolerance and efficacy of Lamuran administered by phleboclysis in 39 patients with peripheral vascular diseases]. Dotti GC Minerva Med; 1973 May; 64(34):1821-30. PubMed ID: 4719379 [No Abstract] [Full Text] [Related]
9. [Insulin in the treatment of trophic disorders caused by chronic obliterating arteriopathies]. Cascone A; Ferrari F G Gerontol; 1968 Dec; 16(12):1385-94. PubMed ID: 5732590 [No Abstract] [Full Text] [Related]
10. The treatment of chronic venous disorder of the leg. Allen S Practitioner; 1970 Aug; 205(226):221-4. PubMed ID: 5480515 [No Abstract] [Full Text] [Related]
11. [Effect of Inderal on intermittent claudication in patients with obliterative arterial disease]. Skawiński S; Wójcikiewicz O; Peiker W Pol Tyg Lek; 1971 Dec; 26(52):2019-21. PubMed ID: 5139589 [No Abstract] [Full Text] [Related]
12. [Treatment of chronic venous insufficiency of the lower extremities]. Vistoli O Clin Ter; 1971 Jul; 58(2):117-44. PubMed ID: 5168208 [No Abstract] [Full Text] [Related]
13. [On the therapeutic activity of hemaseril in treatment of ischemic arteriopathies and phlebopathies]. Tattoni G; Bigazzi P; Gritta G Clin Ter; 1974 Mar; 69(3):225-39. PubMed ID: 4846656 [No Abstract] [Full Text] [Related]
14. [The association of raubasine and ergot derivatives in therapy of peripheral vascular diseases]. Sforza M; Perelli-Ercolini M Minerva Cardioangiol; 1967 Oct; 15(10):655-8. PubMed ID: 5611109 [No Abstract] [Full Text] [Related]
15. Local application of thymoxamine in peripheral vascular disease. Turner P; Harrison J; Schoenfeldt R Lancet; 1969 Jun; 1(7608):1238-9. PubMed ID: 4182414 [No Abstract] [Full Text] [Related]